Epigenetic changes in therapy-related MDS/AML

Medicine and Dentistry

• Combination Therapy 100%
• Malignant Neoplasm 50%
• Radiation Therapy 50%
• Diseases 33%
• Chemotherapy 33%
• Drug 33%
• Cytotoxic Chemotherapy 33%
• Chemotherapeutic Agent 33%
• Granulocyte 33%
• Patient 33%
• Breast Cancer 16%
• Hematologic Malignancy 16%
• Neoplasm 16%
• Exercise 16%
• Epigenomics 16%
• Dihydrotachysterol 16%
• Genetic Predisposition 16%
• Hodgkin's Lymphoma 16%
• Cisplatin 16%
• Chemoradiotherapy 16%
• Asparaginase 16%
• Etoposide 16%
• ABVD 16%
• Fludarabine 16%
• Pelvic Tumor 16%
• BEACOPP 16%
• Testis Cancer 16%
• Lenalidomide 16%
• Therapeutic Procedure 16%
• Female 16%
• Childhood 16%
• Myelodysplastic Syndrome 16%
• Acute Myelogenous Leukemia 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 50%
• Diseases 33%
• Drug 33%
• Neoplasm 16%
• Breast Cancer 16%
• Cisplatin 16%
• Asparaginase 16%
• Hematologic Malignancy 16%
• Dihydrotachysterol 16%
• Etoposide 16%
• Hodgkin Disease 16%
• Pelvis Tumor 16%
• Fludarabine 16%
• Lenalidomide 16%
• Genetic Predisposition 16%
• Antimetabolite 16%
• Testis Cancer 16%